Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11808065 | 0.90 | CES2 (0.42) | LMNACYP2A6MEN1KMT2AALDH1A1 | |
| SCHEMBL12353492 | 0.87 | HPGD (0.36) | LMNATSHRCA2CA4CA5A | |
| SCHEMBL5676701 | 0.86 | MAOA (0.50) | LMNAMEN1KMT2AALDH1A1CYP3A4 | |
| SCHEMBL10340793 | 0.82 | LMNA (0.47) | LMNACYP2A6MEN1KMT2AALDH1A1 | |
| SCHEMBL1000520 | 0.79 | LMNA (0.50) | LMNACYP2A6MEN1KMT2AALDH1A1 | |
| SCHEMBL11144244 | 0.78 | LMNA (0.42) | LMNACYP2A6MEN1KMT2AALDH1A1 | |
| SCHEMBL25146402 | 0.74 | LMNA (0.44) | LMNACYP2A6MEN1KMT2AALDH1A1 | |
| Potassium Ion SCHEMBL6228946 | 0.74 | LMNA (0.44) | LMNACYP2A6MEN1KMT2AALDH1A1 | |
| SCHEMBL11795326 | 0.74 | LMNA (0.44) | LMNACYP2A6MEN1KMT2AALDH1A1 | |
| SCHEMBL10425734 | 0.74 | MEN1 (0.50) | LMNACYP2A6MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119635-A | Ageing-resistant material prepared from recycled polypropylene and preparation method thereof | 肇庆市合亚科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-119119635-A | Ageing-resistant material prepared from recycled polypropylene and preparation method thereof | 肇庆市合亚科技有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-107148423-B | Thionucleoside derivative or salt thereof and pharmaceutical composition | 富士胶片株式会社 | 2021-07-30 | — | — | CN | disclosed |
| EP-3102215-B1 | 4'-DIFLUOROMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF INFLUENZA RNA REPLICATION | RIBOSCIENCE LLC (US) | 2021-06-16 | — | — | EP | disclosed |
| EP-3214090-B1 | THIONUCLEOSIDE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION | FUJIFILM CORP (JP) | 2020-08-19 | — | — | EP | disclosed |
| US-10385089-B2 | Thionucleoside derivative or salt thereof, and pharmaceutical composition | FUJIFILM CORPORATION (JP) | 2019-08-20 | — | — | US | disclosed |
| US-20180319834-A1 | THIONUCLEOSIDE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION | FUJIFILM CORPORATION (JP) | 2018-11-08 | — | — | US | disclosed |
| US-10092649-B2 | 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication | RIBOSCIENCE LLC (US) | 2018-10-09 | — | — | US | disclosed |
| US-10059734-B2 | Thionucleoside derivative or salt thereof, and pharmaceutical composition | FUJIFILM CORPORATION (JP) | 2018-08-28 | — | — | US | disclosed |
| US-20170296664-A1 | 4'-Difluoromethyl Substituted Nucleoside Derivatives as Inhibitors of Influenza RNA Replication | RIBOSCIENCE LLC | 2017-10-19 | — | — | US | disclosed |
| US-4656293-A | Process for preparing organic chlorophosphanes | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-04-07 | — | — | US | disclosed |
| US-4632995-A | Process for the preparation of phenyl- and thienyl-chlorophosphane derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-12-30 | — | — | US | disclosed |
| EP-0144743-A1 | Process for the preparation of organic chlorophosphanes | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-06-19 | — | — | EP | disclosed |
| EP-0122587-A2 | Process for preparing organic chlorophosphanes | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-10-24 | — | — | EP | disclosed |
| US-4319913-A | Substituted benzazaphospholes, herbicidal compositions and the use thereof | MONSANTO COMPANY (US) | 1982-03-16 | — | — | US | disclosed |
| US-RE30279-E | FROM ALKYL OR ARYL HALIDE WITH HALO-SUBSTITUTED TRIVALENT PHOSPHORUS COMPOUNDS AND PHOSPHORUS PENTASULFIDE OR -OXIDE | STAUFFER CHEMICAL COMPANY (US) | 1980-05-20 | — | — | US | disclosed |
| US-4046884-A | N-(α-Aminoalkylidene)phosphor- and phosphonamidates, and method for controlling insects | VELSICOL CHEMICAL CORPORATION (US) | 1977-09-06 | — | — | US | disclosed |
| US-4000239-A | PROCESS FOR SPINNING NAPHTHALATE POLYESTER FIBERS | TEIJIN LIMITED (JA) | 1976-12-28 | — | — | US | disclosed |
| US-3965220-A | AMINE CATALYST | MONSANTO COMPANY (US) | 1976-06-22 | — | — | US | disclosed |
| US-3950413-A | Process for the preparation of phosphonic acid dihalides | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180319834-A1 | THIONUCLEOSIDE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION | SLC11A2, RNASE1, KRAS | LMNA 4093/4885CYP2A6 4108/4885MEN1 2626/4885 |
| US-10385089-B2 | Thionucleoside derivative or salt thereof, and pharmaceutical composition | SLC11A2, RNASE1, KRAS | LMNA 4093/4885CYP2A6 4108/4885MEN1 2626/4885 |
| US-10059734-B2 | Thionucleoside derivative or salt thereof, and pharmaceutical composition | SLC11A2, RNASE1, TYMP | LMNA 4144/4885CYP2A6 4094/4885MEN1 2253/4885 |
| US-10092649-B2 | 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication | RNMT, RNGTT, DUT | LMNA 2116/4885CYP2A6 2716/4885MEN1 4580/4885 |
| US-20170296664-A1 | 4'-Difluoromethyl Substituted Nucleoside Derivatives as Inhibitors of Influenza RNA Replication | RNMT, DUT, RNGTT | LMNA 2212/4885CYP2A6 2688/4885MEN1 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.